NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.2B
P/E ratio
101.6x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 2026227-48.76%
Mar 31, 2025443-302.28%
Mar 31, 2024-219-477.59%
Mar 31, 202358-94.32%
Mar 31, 20221,022+75.60%
Mar 31, 2021582+89.58%
Mar 31, 2020307-79.70%
Mar 31, 20191,512-10.85%
Mar 31, 20181,696-40.47%
Mar 31, 20172,849-3.26%
Mar 31, 20162,945-8.46%
Mar 31, 20153,217+0.34%
Mar 31, 20143,206-13.68%
Mar 31, 20133,714+33.79%
Mar 31, 20122,776
AI Chat